
Research peptides
Selank
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed in Russia as an analog of tuftsin, an immunoglobulin G fragment, extended with Pro-Gly-Pro for stability.
- Container
- Glass vial, crimp seal, flip-top cap
- Storage
- -20 °C, desiccated
- Paperwork
- Lot certificate (HPLC + mass spec) shown before you pay
Lot certificates
You’ll see American Peptides on the lab’s copy. They’re our supplier.
- 10 mg, lot SEL10-0803: 99.83% purity (RP-HPLC), 10.93 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7627
Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.
What researchers study it for
- Anxiety-related behavior in rodent models
- Generalized anxiety disorder (small Russian study)
- GABAergic gene expression
- Enkephalin-degrading enzyme inhibition
How it is thought to work
Selank's mechanism is not established. Proposed actions include inhibiting enzymes that break down enkephalins, allosteric modulation of GABA receptor binding in radioligand studies, and changes in expression of GABA-related genes. Most of this work comes from the developing Russian research groups.
Where the research stands
Reported approved in Russia; not FDA-approved. Reported as approved in Russia for anxiety; human evidence is limited to small Russian-language studies, such as a 62-patient comparison with medazepam, and no FDA approval was found.
Sources
- Volkova A, Shadrina M, Kolomin T, Andreeva L, Limborska S, Myasoedov N, Slominsky P (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission.. Front Pharmacol.
- Zozulia AA, Neznamov GG, Siuniakov TS, Kost NV, et al. (2008). [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].. Zh Nevrol Psikhiatr Im S S Korsakova.
- Zozulya AA, Kost NV, Yu Sokolov O, Gabaeva MV, et al. (2001). The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity.. Bull Exp Biol Med.
- Vyunova TV, Andreeva L, Shevchenko K, Myasoedov N (2018). Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.. Protein Pept Lett.
- Rahman OF, Lee SJ, Seeds WA (2026). Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.. J Am Acad Orthop Surg Glob Res Rev.
Read more
For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.
